Point72 Hong Kong LTD Xenon Pharmaceuticals Inc. Transaction History
Point72 Hong Kong LTD
- $1.5 Billion
- Q1 2025
A detailed history of Point72 Hong Kong LTD transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Point72 Hong Kong LTD holds 329 shares of XENE stock, worth $10,110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
329Holding current value
$10,110% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
69.9MCall Options Held
444KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$176 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$141 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$116 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$102 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$94.9 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $1.91B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...